Drug interactions: Most studies of clinically substantial drug interactions developing with the barbiturates have included phenobarbital. pentobarbital will decrease the level or effect of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mainly because these patients could